Xynos Konstantinos 4
4 · Replimune Group, Inc. · Filed Nov 20, 2024
Insider Transaction Report
Form 4
Xynos Konstantinos
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-11-18$10.78/sh−7,246$78,112→ 109,885 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock (the "Shares") sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreements under which the RSUs were granted and does not represent a discretionary sale by the Reporting Person.